Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of General vs Spinal-Epidural Anesthesia on Ferroptosis and Mitochondrial Peptides in Kidney Transplant
NCT07678073Recruiting
- Sponsor
- Gaziantep University
- Start
- Mar 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Open-label trial of sevoflurane and bupivacaine in end stage renal disease (ESRD) (2 arms), sponsored by Gaziantep University. Primary endpoint: Serum ferroptosis-related biomarkers (Fe, TFRC1, GPX4, MDA, ACSL4) and mitochondrial-derived peptides (humanin and MOTS-c). Started Mar 2026; status: recruiting.
02
Drugs
sevofluranebupivacaine
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT07678073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07678073.